Skip to main content
Top
Published in: Cardiovascular Ultrasound 1/2011

Open Access 01-11-2011 | Research

Impact of Chronic Kidney Disease on the Presence and Severity of Aortic Stenosis in Patients at High Risk for Coronary Artery Disease

Authors: Chiaki Masuda, Kaoru Dohi, Yuko Sakurai, Yuri Bessho, Harumi Fukuda, Shinobu Fujii, Tadafumi Sugimoto, Masaki Tanabe, Katsuya Onishi, Katsuya Shiraki, Masaaki Ito, Tsutomu Nobori

Published in: Cardiovascular Ultrasound | Issue 1/2011

Login to get access

Abstract

Objective

We evaluated the impact of chronic kidney disease (CKD) on the presence and severity of aortic stenosis (AS) in patients at high risk for coronary artery disease (CAD).

Methods

One hundred and twenty consecutive patients who underwent invasive coronary angiography were enrolled. Aortic valve area (AVA) was calculated by the continuity equation using transthoracic echocardiography, and was normalized by body surface area (AVA index).

Results

Among all 120 patients, 78% had CAD, 55% had CKD (stage 3: 81%; stage 4: 19%), and 34% had AS (AVA < 2.0cm2). Patients with AS were older, more often female, and had a higher frequency of CKD than those without AS, but the prevalence of CAD and most other coexisting conventional risk factors was similar between patients with and without AS. Multivariate linear regression analysis indicated that only CKD and CAD were independent determinants of AVA index with standardized coefficients of -0.37 and -0.28, respectively. When patients were divided into 3 groups (group 1: absence of CKD and CAD, n = 16; group 2: presence of either CKD or CAD, n = 51; and group 3: presence of both CKD and CAD, n = 53), group 3 had the smallest AVA index (1.19 ± 0.30*# cm2/m2, *p < 0.05 vs. group 1: 1.65 ± 0.32 cm2/m2, and #p < 0.05 vs. group 2: 1.43 ± 0.29* cm2/m2) and the highest peak velocity across the aortic valve (1.53 ± 0.41*# m/sec; *p < 0.05 vs. group 1: 1.28 ± 0.29 m/sec, and #p < 0.05 vs. group 2: 1.35 ± 0.27 m/sec).

Conclusion

CKD, even pre-stage 5 CKD, has a more powerful impact on the presence and severity of AS than other conventional risk factors for atherosclerosis in patients at high risk for CAD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS: Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999, 341: 142-147. 10.1056/NEJM199907153410302CrossRefPubMed Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS: Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999, 341: 142-147. 10.1056/NEJM199907153410302CrossRefPubMed
2.
go back to reference Rosenhek R, Klaar U, Schemper M, Scholten C, Heger M, Gabriel H, Binder T, Maurer G, Baumgartner H: Mild and moderate aortic stenosis: natural history and risk stratification by echocardiography. Eur Heart J. 2004, 25: 199-205. 10.1016/j.ehj.2003.12.002CrossRefPubMed Rosenhek R, Klaar U, Schemper M, Scholten C, Heger M, Gabriel H, Binder T, Maurer G, Baumgartner H: Mild and moderate aortic stenosis: natural history and risk stratification by echocardiography. Eur Heart J. 2004, 25: 199-205. 10.1016/j.ehj.2003.12.002CrossRefPubMed
3.
go back to reference Sui SJ, Ren MY, Xu FY, Zhang Y: A high association of aortic valve sclerosis detected by transthoracic echocardiography with coronary arteriosclerosis. Cardiology. 2007, 108: 322-330. 10.1159/000099103CrossRefPubMed Sui SJ, Ren MY, Xu FY, Zhang Y: A high association of aortic valve sclerosis detected by transthoracic echocardiography with coronary arteriosclerosis. Cardiology. 2007, 108: 322-330. 10.1159/000099103CrossRefPubMed
4.
go back to reference Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis. 1996, 27: 394-401. 10.1016/S0272-6386(96)90363-7CrossRefPubMed Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis. 1996, 27: 394-401. 10.1016/S0272-6386(96)90363-7CrossRefPubMed
5.
go back to reference Perkovic V, Hunt D, Griffin SV, du Plessis M, Becker GJ: Accelerated progression of calcific aortic stenosis in dialysis patients. Nephron Clin Pract. 2003, 94: c40-c45. 10.1159/000071280CrossRefPubMed Perkovic V, Hunt D, Griffin SV, du Plessis M, Becker GJ: Accelerated progression of calcific aortic stenosis in dialysis patients. Nephron Clin Pract. 2003, 94: c40-c45. 10.1159/000071280CrossRefPubMed
6.
go back to reference Floege J, Ketteler M: Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant. 2004, 19 (suppl 5): V59-V66.CrossRefPubMed Floege J, Ketteler M: Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant. 2004, 19 (suppl 5): V59-V66.CrossRefPubMed
7.
go back to reference Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003, 108: 2154-2169. 10.1161/01.CIR.0000095676.90936.80CrossRefPubMed Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003, 108: 2154-2169. 10.1161/01.CIR.0000095676.90936.80CrossRefPubMed
8.
go back to reference Ureña P, Malergue MC, Goldfarb B, Prieur P, Guédon-Rapoud C, Pétrover M: Evolutive aortic stenosis in hemodialysis patients: analysis of risk factors. Nephrologie. 1999, 20: 217-225.PubMed Ureña P, Malergue MC, Goldfarb B, Prieur P, Guédon-Rapoud C, Pétrover M: Evolutive aortic stenosis in hemodialysis patients: analysis of risk factors. Nephrologie. 1999, 20: 217-225.PubMed
9.
go back to reference Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM: Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?. J Am Coll Cardiol. 2002, 39: 695-701. 10.1016/S0735-1097(01)01781-8CrossRefPubMed Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM: Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?. J Am Coll Cardiol. 2002, 39: 695-701. 10.1016/S0735-1097(01)01781-8CrossRefPubMed
10.
go back to reference Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med. 2006, 354: 2473-2483. 10.1056/NEJMra054415CrossRefPubMed Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med. 2006, 354: 2473-2483. 10.1056/NEJMra054415CrossRefPubMed
11.
go back to reference , : K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Part 4. Definition and classification of stages of chronic kidney disease. Am J Kidney Dis. 2002, 39 (Suppl 1): S46-S75. , : K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Part 4. Definition and classification of stages of chronic kidney disease. Am J Kidney Dis. 2002, 39 (Suppl 1): S46-S75.
12.
go back to reference Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, : Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009, 53: 982-992. 10.1053/j.ajkd.2008.12.034CrossRefPubMed Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, : Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009, 53: 982-992. 10.1053/j.ajkd.2008.12.034CrossRefPubMed
13.
go back to reference , : Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005, 18: 1440-1463. 10.1016/j.echo.2005.10.005CrossRef , : Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005, 18: 1440-1463. 10.1016/j.echo.2005.10.005CrossRef
14.
go back to reference Singh B, Mohan JC: Doppler echocardiographic determination of aortic and pulmonary valve orifice areas in normal adult subjects. Int J Cardiol. 1992, 37: 73-78. 10.1016/0167-5273(92)90134-OCrossRefPubMed Singh B, Mohan JC: Doppler echocardiographic determination of aortic and pulmonary valve orifice areas in normal adult subjects. Int J Cardiol. 1992, 37: 73-78. 10.1016/0167-5273(92)90134-OCrossRefPubMed
15.
go back to reference Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA: Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 2002, 15: 167-184. 10.1067/mje.2002.120202CrossRefPubMed Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA: Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 2002, 15: 167-184. 10.1067/mje.2002.120202CrossRefPubMed
16.
go back to reference Garcia MJ, Rodriguez L, Ares M, Griffin BP, Thomas JD, Klein AL: Differentiation of constrictive pericarditis from restrictive cardiomyopathy: assessment of left ventricular diastolic velocities in longitudinal axis by Doppler tissue imaging. J Am Coll Cardiol. 1996, 27: 108-114.CrossRefPubMed Garcia MJ, Rodriguez L, Ares M, Griffin BP, Thomas JD, Klein AL: Differentiation of constrictive pericarditis from restrictive cardiomyopathy: assessment of left ventricular diastolic velocities in longitudinal axis by Doppler tissue imaging. J Am Coll Cardiol. 1996, 27: 108-114.CrossRefPubMed
17.
go back to reference Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA: Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 1997, 30: 1527-1533. 10.1016/S0735-1097(97)00344-6CrossRefPubMed Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA: Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 1997, 30: 1527-1533. 10.1016/S0735-1097(97)00344-6CrossRefPubMed
18.
go back to reference Zoghbi WA, Farmer KL, Soto JG, Nelson JG, Quinones MA: Accurate noninvasive quantification of stenotic aortic valve area by Doppler echocardiography. Circulation. 1986, 73: 452-459. 10.1161/01.CIR.73.3.452CrossRefPubMed Zoghbi WA, Farmer KL, Soto JG, Nelson JG, Quinones MA: Accurate noninvasive quantification of stenotic aortic valve area by Doppler echocardiography. Circulation. 1986, 73: 452-459. 10.1161/01.CIR.73.3.452CrossRefPubMed
19.
go back to reference Oh JK, Taliercio CP, Holmes DR, Reeder GS, Bailey KR, Seward JB, Tajik AJ: Prediction of the severity of aortic stenosis by Doppler aortic valve area determination: prospective Doppler-catheterization correlation in 100 patients. J Am Coll Cardiol. 1988, 11: 1227-1234. 10.1016/0735-1097(88)90286-0CrossRefPubMed Oh JK, Taliercio CP, Holmes DR, Reeder GS, Bailey KR, Seward JB, Tajik AJ: Prediction of the severity of aortic stenosis by Doppler aortic valve area determination: prospective Doppler-catheterization correlation in 100 patients. J Am Coll Cardiol. 1988, 11: 1227-1234. 10.1016/0735-1097(88)90286-0CrossRefPubMed
20.
go back to reference Bonow RO, Carabello BA, Kanu C, de LA, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006, 114: e84-e231. 10.1161/CIRCULATIONAHA.106.176857CrossRefPubMed Bonow RO, Carabello BA, Kanu C, de LA, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006, 114: e84-e231. 10.1161/CIRCULATIONAHA.106.176857CrossRefPubMed
21.
go back to reference Freeman RV, Otto CM: Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005, 111: 3316-3326. 10.1161/CIRCULATIONAHA.104.486738CrossRefPubMed Freeman RV, Otto CM: Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005, 111: 3316-3326. 10.1161/CIRCULATIONAHA.104.486738CrossRefPubMed
22.
go back to reference Poggianti E, Venneri L, Chubuchny V, Jambrik Z, Baroncini LA, Picano E: Aortic valve sclerosis is associated with systemic endothelial dysfunction. J Am Coll Cardiol. 2003, 41: 136-141.CrossRefPubMed Poggianti E, Venneri L, Chubuchny V, Jambrik Z, Baroncini LA, Picano E: Aortic valve sclerosis is associated with systemic endothelial dysfunction. J Am Coll Cardiol. 2003, 41: 136-141.CrossRefPubMed
23.
go back to reference Agmon Y, Khandheria BK, Jamil Tajik A, Seward JB, Sicks JD, Fought AJ, O'Fallon WM, Smith TF, Wiebers DO, Meissner I: Inflammation, infection, and aortic valve sclerosis: Insights from the Olmsted County (Minnesota) population. Atherosclerosis. 2004, 174: 337-342. 10.1016/j.atherosclerosis.2004.01.028CrossRefPubMed Agmon Y, Khandheria BK, Jamil Tajik A, Seward JB, Sicks JD, Fought AJ, O'Fallon WM, Smith TF, Wiebers DO, Meissner I: Inflammation, infection, and aortic valve sclerosis: Insights from the Olmsted County (Minnesota) population. Atherosclerosis. 2004, 174: 337-342. 10.1016/j.atherosclerosis.2004.01.028CrossRefPubMed
24.
go back to reference Aronow WS, Ahn C, Shirani J, Kronzon I: Comparison of frequency of new coronary events in older subjects with and without valvular aortic sclerosis. Am J Cardiol. 1999, 83: 599-600. 10.1016/S0002-9149(98)00922-9CrossRefPubMed Aronow WS, Ahn C, Shirani J, Kronzon I: Comparison of frequency of new coronary events in older subjects with and without valvular aortic sclerosis. Am J Cardiol. 1999, 83: 599-600. 10.1016/S0002-9149(98)00922-9CrossRefPubMed
25.
go back to reference Shah SJ, Ristow B, Ali S, Na BY, Schiller NB, Whooley MA: Acute myocardial infarction in patients with versus without aortic valve sclerosis and effect of statin therapy (from the Heart and Soul Study). Am J Cardiol. 2007, 99: 1128-1133. 10.1016/j.amjcard.2006.11.057CrossRefPubMedPubMedCentral Shah SJ, Ristow B, Ali S, Na BY, Schiller NB, Whooley MA: Acute myocardial infarction in patients with versus without aortic valve sclerosis and effect of statin therapy (from the Heart and Soul Study). Am J Cardiol. 2007, 99: 1128-1133. 10.1016/j.amjcard.2006.11.057CrossRefPubMedPubMedCentral
26.
go back to reference Warren BA, Yong JLC: Calcification of the aortic valve: its progression and grading. Pathology. 1997, 29: 360-368. 10.1080/00313029700169315CrossRefPubMed Warren BA, Yong JLC: Calcification of the aortic valve: its progression and grading. Pathology. 1997, 29: 360-368. 10.1080/00313029700169315CrossRefPubMed
27.
go back to reference Aikawa E, Aikawa M, Libby P, Figueiredo JL, Rusanescu G, Iwamoto Y, Fukuda D, Kohler RH, Shi GP, Jaffer FA, Weissleder R: Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation. 2009, 119: 1785-1794. 10.1161/CIRCULATIONAHA.108.827972CrossRefPubMedPubMedCentral Aikawa E, Aikawa M, Libby P, Figueiredo JL, Rusanescu G, Iwamoto Y, Fukuda D, Kohler RH, Shi GP, Jaffer FA, Weissleder R: Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation. 2009, 119: 1785-1794. 10.1161/CIRCULATIONAHA.108.827972CrossRefPubMedPubMedCentral
28.
go back to reference Craver L, Marco MP, Martínez I, Rue M, Borràs M, Martín ML, Sarró F, Valdivielso JM, Fernández E: Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges. Nephrol Dial Transplant. 2007, 22: 1171-1176. 10.1093/ndt/gfl718CrossRefPubMed Craver L, Marco MP, Martínez I, Rue M, Borràs M, Martín ML, Sarró F, Valdivielso JM, Fernández E: Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges. Nephrol Dial Transplant. 2007, 22: 1171-1176. 10.1093/ndt/gfl718CrossRefPubMed
29.
go back to reference Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR: Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol. 2009, 20: 381-738. 10.1681/ASN.2008040349CrossRefPubMedPubMedCentral Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR: Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol. 2009, 20: 381-738. 10.1681/ASN.2008040349CrossRefPubMedPubMedCentral
30.
go back to reference Reichel H, Deibert B, Schmidt-Gayk H, Ritz E: Calcium metabolism in early chronic renal failure: Implications for the pathogenesis of hyperparathyroidism. Nephrol Dial Transplan. 1991, 6: 162-169.CrossRef Reichel H, Deibert B, Schmidt-Gayk H, Ritz E: Calcium metabolism in early chronic renal failure: Implications for the pathogenesis of hyperparathyroidism. Nephrol Dial Transplan. 1991, 6: 162-169.CrossRef
31.
go back to reference Pitts TO, Piraino BH, Mitro R, Chen TC, Segre GV, Greenberg A, Puschett JB: Hyperparathyroidism and 1, 25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab. 1988, 67: 876-881. 10.1210/jcem-67-5-876CrossRefPubMed Pitts TO, Piraino BH, Mitro R, Chen TC, Segre GV, Greenberg A, Puschett JB: Hyperparathyroidism and 1, 25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab. 1988, 67: 876-881. 10.1210/jcem-67-5-876CrossRefPubMed
32.
go back to reference Kates DM, Sherrard DJ, Andress DL: Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure. Am J Kidney Dis. 1997, 30: 809-813. 10.1016/S0272-6386(97)90086-XCrossRefPubMed Kates DM, Sherrard DJ, Andress DL: Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure. Am J Kidney Dis. 1997, 30: 809-813. 10.1016/S0272-6386(97)90086-XCrossRefPubMed
33.
go back to reference Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM: Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol. 1997, 29: 630-634. 10.1016/S0735-1097(96)00563-3CrossRefPubMed Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM: Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol. 1997, 29: 630-634. 10.1016/S0735-1097(96)00563-3CrossRefPubMed
34.
go back to reference Aronow WS, Schwartz KS, Koenigsberg M: Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol. 1987, 59: 998-999. 10.1016/0002-9149(87)91144-1CrossRefPubMed Aronow WS, Schwartz KS, Koenigsberg M: Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol. 1987, 59: 998-999. 10.1016/0002-9149(87)91144-1CrossRefPubMed
35.
go back to reference Mohler ER, Sheridan MJ, Nichols R, Harvey WP, Waller BF: Development and progression of aortic valve stenosis: atherosclerosis risk factors-a causal relationship? A clinical morphologic study. Clin Cardiol. 1991, 14: 995-999. 10.1002/clc.4960141210CrossRefPubMed Mohler ER, Sheridan MJ, Nichols R, Harvey WP, Waller BF: Development and progression of aortic valve stenosis: atherosclerosis risk factors-a causal relationship? A clinical morphologic study. Clin Cardiol. 1991, 14: 995-999. 10.1002/clc.4960141210CrossRefPubMed
36.
go back to reference Lindroos M, Kupari M, Valvanne J, Strandberg T, Heikkila J, Tilvis R: Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J. 1994, 15: 865-870.PubMed Lindroos M, Kupari M, Valvanne J, Strandberg T, Heikkila J, Tilvis R: Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J. 1994, 15: 865-870.PubMed
37.
go back to reference Boon A, Cheriex E, Lodder J, Kessels F: Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve. Heart. 1997, 78: 472-472.CrossRefPubMedPubMedCentral Boon A, Cheriex E, Lodder J, Kessels F: Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve. Heart. 1997, 78: 472-472.CrossRefPubMedPubMedCentral
38.
go back to reference Peltier M, Trojette F, Sarano ME, Grigioni F, Slama MA, Tribouilloy CM: Relation between cardiovascular risk factors and nonrheumatic severe calcific aortic stenosis among patients with a three-cuspid aortic valve. Am J Cardiol. 2003, 91: 97-99. 10.1016/S0002-9149(02)03010-2CrossRefPubMed Peltier M, Trojette F, Sarano ME, Grigioni F, Slama MA, Tribouilloy CM: Relation between cardiovascular risk factors and nonrheumatic severe calcific aortic stenosis among patients with a three-cuspid aortic valve. Am J Cardiol. 2003, 91: 97-99. 10.1016/S0002-9149(02)03010-2CrossRefPubMed
39.
go back to reference Jander N, Minners J, Holme I, Gerdts E, Boman K, Brudi P, Chambers JB, Egstrup K, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Rossebø A, Pedersen TR, Skjærpe T, Willenheimer R, Wachtell K, Neumann FJ, Gohlke-Bärwolf C: Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction. Circulation. 2011, 123: 887-895. 10.1161/CIRCULATIONAHA.110.983510CrossRefPubMed Jander N, Minners J, Holme I, Gerdts E, Boman K, Brudi P, Chambers JB, Egstrup K, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Rossebø A, Pedersen TR, Skjærpe T, Willenheimer R, Wachtell K, Neumann FJ, Gohlke-Bärwolf C: Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction. Circulation. 2011, 123: 887-895. 10.1161/CIRCULATIONAHA.110.983510CrossRefPubMed
Metadata
Title
Impact of Chronic Kidney Disease on the Presence and Severity of Aortic Stenosis in Patients at High Risk for Coronary Artery Disease
Authors
Chiaki Masuda
Kaoru Dohi
Yuko Sakurai
Yuri Bessho
Harumi Fukuda
Shinobu Fujii
Tadafumi Sugimoto
Masaki Tanabe
Katsuya Onishi
Katsuya Shiraki
Masaaki Ito
Tsutomu Nobori
Publication date
01-11-2011
Publisher
BioMed Central
Published in
Cardiovascular Ultrasound / Issue 1/2011
Electronic ISSN: 1476-7120
DOI
https://doi.org/10.1186/1476-7120-9-31

Other articles of this Issue 1/2011

Cardiovascular Ultrasound 1/2011 Go to the issue